1. Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

2. Baseline Differences for Women With CVD According to Aspirin Dose
Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

3. Clinical Outcomes According to Aspirin Use and Dose
Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

4. Adjusted Cox proportional hazards analyses of time to adverse outcomes among women with CVD (n=8928)
Jeffrey S. Berger, et al. Circ Card Qual Out 2009;2:78-87

5. Subgroup analyses according to aspirin use
Jeffrey S. Berger, et al. Circ Card Qual Out 2009;2:78-87

6. Clinical outcomes according to aspirin use
Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

7. Clinical outcomes according to aspirin dose
Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

8. Clinical Perspective
Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87